Alnylam Pharmaceuticals reported $676.71M in Loan Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Agios Pharmaceuticals AGIO:US $ 0.28M 0M
Alnylam Pharmaceuticals ALNY:US $ 676.71M 1.01M
Amgen AMGN:US $ 36010M 2788M
Arrowhead Research ARWR:US $ 0 0
Avrobio Inc AVRO:US $ 15.02M 75K
Biocryst Pharmaceuticals BCRX:US $ 604.46M 19M
Biomarin Pharmaceutical BMRN:US $ 1080.06M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
Intercept Pharmaceuticals ICPT:US $ 716.88M 177.1M
IONIS PHARMACEUT IONS:US $ 1247.93M 19.91M
Mirati Therapeutics MRTX:US $ 0M 0M
Moderna Inc MRNA:US $ 646M 47M
Neurocrine Biosciences NBIX:US $ 377.7M 42.6M
Novartis NVS:US $ 24373M 150M
Ptc Therapeutics PTCT:US $ 975.65M 0.99M
Regeneron Pharmaceuticals REGN:US $ 2700.4M 720.4M
Regulus Therapeutics RGLS:US $ 3.59M 1.08M
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1098.85M 1.97M
Takeda 4502:JP Y 4141418M 90521M
Ultragenyx Pharmaceutical RARE:US $ 0M 0.41M
Vertex Pharmaceuticals VRTX:US $ 495.5M 14.3M
Xencor XNCR:US $ 0M 0M
YTE INCY:US $ 31.38M 0.25M